Neoadjuvant Taxotere

NCT00206505 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Taxotere

Sponsor

Baylor Breast Care Center

Collaborators

[object Object]